论文信息 - First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts - 字舞流文

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

A. Tordai | H. Andrikovics | B. Kajtár | A. Bors | A. Kozma | S. Nahajevszky | A. Szilvási | E. Ádám | A. Barta | A. Poros